|
|
|
Image Courtesy BBC |
A genetic disorder that can
cause a fatal rise in body temperature in some patients undergoing general
anesthesia may hold the key to a cure for heat stroke, according to research
published in the April 4 edition of the journal Cell. The findings further suggest that antioxidants, like
those currently being tested to protect the lungs of cystic fibrosis patients,
may also protect those genetically prone to suffer heat stroke.
According to the current study authors, all U.S. operating rooms should, but do
not always, have a supply of a drug called dantrolene on hand, which causes
muscles to relax by a unique mechanism. Dantrolene is a must in the rare cases
where patients receiving general anesthesia unexpectedly go into whole-body
muscle contractions as part of an inherited condition called malignant hyperthermia
(MH). Occurring in one in about 10,000 adult patients undergoing general
anesthesia, and more frequently in children, MH reactions alter the acid
content of blood and tissues, increase heart rate, cause muscle rigidity and
trigger a rapid rise in body temperature up to 112° F. Kidney failure and
potentially fatal heart arrhythmias can result in the worse cases. MH received
national news coverage recently because of the unfortunate case of an
18-year-old
Researchers are also interested in MH because it may be caused by the same
biochemical pathways as heat stroke, a much more common condition that has caused
more
”Along with cardiac abnormalities, heat stroke is a major culprit in unexpected
sudden deaths of otherwise fit, young athletes and soldiers,” said Robert T. Dirksen, Ph.D., associate
professor of Pharmacology and Physiology at the University of Rochester Medical
Center. “With a better knowledge of these mechanisms, we can begin to better
diagnose and treat both disorders, and hopefully, save some lives,” said
Dirksen, a co-author on the study.
The Perfect Switch
To drive life processes, human cells expend tremendous energy to continually
push positively charged calcium ions both out of cells, and into internal
calcium storage compartments. This creates charge/calcium gradients across cell
membranes, a powerful source of potential energy. Cells harness this energy to
send
nerve signals, regulate genes and trigger muscle contraction. Muscle movement
in the body is regulated by precisely controlled increases in calcium ion
concentration acting as a biochemical switch.
Going into the current study, the team knew from the literature that a genetic
mutation – a small, random mistake in the genetic code – causes MH
susceptibility in humans. They also knew that the mutation was located in a
gene that codes for ryanodine receptor proteins. These calcium channels provide
a pathway for calcium in the internal storage compartment, the sarcoplasmic
reticulum, to be released into the muscle cell to cause contraction.
For the current project, researchers genetically engineered mice with a
mutation seen in human MH disease. They found that these mice indeed exhibited
full-body contractions that lead to death during exposure to anesthesia (e.g.
halothane), a hallmark of malignant hyperthermia. Unexpectedly, the mice were also
found to experience similar, life-threatening episodes during brief exposure to
environmental heat stress (105oF). These results establish a surprising
connection between altered ryanodine receptor activity and heat stroke, with
the mutated calcium channel being more likely to exhibit uncontrolled calcium
release and muscle contraction in response to heat.
Furthermore, the team demonstrated that increased calcium ion leakage from
mutated ryanodine receptors during heat stress caused a profound increase in
free radical production. Also called reactive oxygen species (ROS) and nitrogen
species (RNS), free radicals are highly reactive molecules that can destroy
sensitive cell components and hasten cell death. Free radicals are largely
created as a side effect when structures within all human cells, the
mitochondria, use oxygen to turn food into an energy-storing molecule called
adenosine triphosphate (ATP). To drive ATP production, electrons are passed
along a chain of enzymes within the mitochondria. When some of these electrons
are not passed along effectively, they combine with oxygen and nitrogen to form
free radicals. Disease processes tend to create far higher levels of free
radicals than the body’s naturally occurring antioxidants can mop up.
In the current study, results showed that free radical production in muscle
nearly doubled in the genetically altered mice, and that it rose even more
during heat stress. Researchers also found that the increase in free radicals
results from increased calcium leak from the mutated calcium channels in the
sarcoplasmic reticulum, potentially driving increased ROS/RNS production by
nearby mitochondria. In addition, the increase in ROS/RNS levels were in turn
found to travel back to, and further alter, mutated ryanodine receptor calcium
channels.
This “vicious feed-forward cycle” caused the calcium leak to further worsen,
the calcium channels to become extremely heat sensitive and muscles to contract
uncontrollably in response to both anesthesia and heat. Uncontrolled
contractions can break apart muscle cells, releasing toxic cellular metabolites
into the bloodstream that ultimately trigger kidney failure and throw the
heartbeat out of rhythm. Even in the absence of such acute events, increased
oxidative stress in the muscle of mutant mice over the long term was also found
to distort the shape of mitochondria and weaken muscle contraction (myopathy).
Most importantly, simply including an antioxidant, N-acetylcysteine (NAC), in
the animal’s water supply resulted in a marked reduction in sensitivity to heat
stress, improved mitochondrial health and restoration of muscle function in
aged mice. NAC is currently in phase 2 human clinical trials for patients with
cystic fibrosis, where disease creates free radicals that damage lung tissue.
Researchers from the
“We found that destructive cycles of calcium leakage and excess free radical production
damage mitochondria and contribute to the deterioration of muscle function in
aged animals,” Dirksen said. “In successfully constructing the first mouse
model of human MH, we unwittingly generated the first animal model of heat
stroke that will undoubtedly be tremendously useful in better understanding
these disorders and in accelerating the design of safe and effective treatments
for both conditions.”
“Malignant hyperthermia syndrome, a potentially fatal inherited disorder, is
most often ‘triggered’ by certain gas anesthetics and the paralyzing drug
succinylcholine,” said Henry
Rosenberg, M.D., president of the Malignant Hyperthermia
Society of the United States and professor of anesthesiology at Mount Sinai
School of Medicine, N.Y. “In the naturally occurring animal model, certain
breeds of swine, the syndrome is also precipitated by environmental conditions.
It has long been debated as to whether some cases of heat stroke and
exercise-induced muscle breakdown in humans are related to malignant hyperthermia
as well. This study defines a biochemical pathway that might very well clarify
the relationship between anesthesia-induced malignant hyperthermia and heat
stroke. This elegant study, using modern molecular techniques, opens new
avenues for the study of the not-uncommon problem of heat stroke and
exercise-induced muscle breakdown and the risk for malignant hyperthermia.”
For
more media inquiries, contact:
Greg Williams
(585) 273-1757
greg_williams@urmc.rochester.edu